Back to Search
Start Over
Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests
- Source :
- Malaria Journal, Malaria Journal, BioMed Central, 2010, 9, pp.129. ⟨10.1186/1475-2875-9-129⟩, Malaria Journal, Vol 9, Iss 1, p 129 (2010)
- Publication Year :
- 2010
- Publisher :
- BioMed Central, 2010.
-
Abstract
- Background Accurate diagnosis is essential for prompt and appropriate treatment of malaria. While rapid diagnostic tests (RDTs) offer great potential to improve malaria diagnosis, the sensitivity of RDTs has been reported to be highly variable. One possible factor contributing to variable test performance is the diversity of parasite antigens. This is of particular concern for Plasmodium falciparum histidine-rich protein 2 (PfHRP2)-detecting RDTs since PfHRP2 has been reported to be highly variable in isolates of the Asia-Pacific region. Methods The pfhrp2 exon 2 fragment from 458 isolates of P. falciparum collected from 38 countries was amplified and sequenced. For a subset of 80 isolates, the exon 2 fragment of histidine-rich protein 3 (pfhrp3) was also amplified and sequenced. DNA sequence and statistical analysis of the variation observed in these genes was conducted. The potential impact of the pfhrp2 variation on RDT detection rates was examined by analysing the relationship between sequence characteristics of this gene and the results of the WHO product testing of malaria RDTs: Round 1 (2008), for 34 PfHRP2-detecting RDTs. Results Sequence analysis revealed extensive variations in the number and arrangement of various repeats encoded by the genes in parasite populations world-wide. However, no statistically robust correlation between gene structure and RDT detection rate for P. falciparum parasites at 200 parasites per microlitre was identified. Conclusions The results suggest that despite extreme sequence variation, diversity of PfHRP2 does not appear to be a major cause of RDT sensitivity variation.
- Subjects :
- MESH: Sequence Analysis, DNA
MESH: Reagent Kits, Diagnostic
Protozoan Proteins
Polymerase Chain Reaction
law.invention
Exon
0302 clinical medicine
law
MESH: Animals
MESH: Genetic Variation
Malaria, Falciparum
MESH: Protozoan Proteins
Polymerase chain reaction
MESH: Plasmodium falciparum
Genetics
Immunoassay
0303 health sciences
biology
MESH: Malaria, Falciparum
3. Good health
Infectious Diseases
MESH: Immunoassay
[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT]
lcsh:Arctic medicine. Tropical medicine
lcsh:RC955-962
Sequence analysis
030231 tropical medicine
Plasmodium falciparum
MESH: DNA, Protozoan
Antigens, Protozoan
Sensitivity and Specificity
lcsh:Infectious and parasitic diseases
03 medical and health sciences
Genetic variation
parasitic diseases
medicine
Animals
Humans
lcsh:RC109-216
Gene
030304 developmental biology
MESH: Humans
Research
Genetic Variation
MESH: Polymerase Chain Reaction
Sequence Analysis, DNA
DNA, Protozoan
medicine.disease
biology.organism_classification
MESH: Sensitivity and Specificity
Parasitology
Reagent Kits, Diagnostic
Malaria
MESH: Antigens, Protozoan
Subjects
Details
- Language :
- English
- ISSN :
- 14752875
- Volume :
- 9
- Database :
- OpenAIRE
- Journal :
- Malaria Journal
- Accession number :
- edsair.doi.dedup.....3f1b67b0c227f04a0cf1403875e7ecac
- Full Text :
- https://doi.org/10.1186/1475-2875-9-129⟩